21 USC 1705 - Development, submission, implementation, and assessment of National Drug Control Strategy

1 So in original. The comma probably should not appear.

enforcement authorities, and variations in the volumes of vehicles and pedestrians crossing through ports of entry along the international border between the United States and Canada.

2 So in original. Probably should be followed by “and”.

3 So in original.

4 Probably should be “(h)”.

shall be included in each report submitted under subsection (span).

5 Probably should be “(d)”.

Editorial Notes

References in Text

The Federal Food, Drug, and Cosmetic Act, referred to in subsec. (f)(3)(A)(i)(IV), is act June 25, 1938, ch. 675, 52 Stat. 1040, which is classified generally to chapter 9 (§ 301 et seq.) of this title. For complete classification of this Act to the Code, see section 301 of this title and Tables.

This chapter, referred to in subsec. (g)(2), (3)(B), was in the original “this title”, meaning title VII of div. C of Puspan. L. 105–277, Oct. 21, 1998, 112 Stat. 2681–670, which is classified principally to this chapter. For complete classification of title VII to the Code, see Short Title note set out under section 1701 of this title and Tables.

Amendments

2022—Subsec. (h)(7). Puspan. L. 117–263 added par. (7).

2019—Puspan. L. 116–74, § 2(c)(1)(B), amended directory language of Puspan. L. 115–271, § 8221(a). See 2018 Amendment note below.

Puspan. L. 116–74, § 2(a)(2), substituted “National Drug Control Program agencies” for “National Drug Control Program Agencies” wherever appearing.

Puspan. L. 116–74, § 2(a)(1), substituted “National Drug Control Program agency” for “National Drug Control Program Agency” wherever appearing.

Subsec. (c)(1)(N)(ii). Puspan. L. 116–74, § 2(d)(1)(A), substituted “Program agencies” for “Programs”.

Subsec. (c)(1)(N)(iii). Puspan. L. 116–74, § 2(d)(1)(B), substituted “Program agencies” for “Agencies”.

Subsec. (c)(2). Puspan. L. 116–74, § 2(d)(2), substituted “paragraph (1)(M)” for “paragraph (1)” in introductory provisions.

Subsec. (f)(2). Puspan. L. 116–74, § 2(d)(3)(A), substituted “Office” for “office”.

Subsec. (f)(3)(A)(ii)(III). Puspan. L. 116–74, § 2(d)(3)(B)(i), substituted “substance; and” for “substance;”.

Subsec. (f)(3)(A)(ii)(IV). Puspan. L. 116–74, § 2(d)(3)(B)(ii), substituted “governments.” for “governments;”.

Subsec. (g)(3)(B). Puspan. L. 116–74, § 2(d)(4), made technical amendment to reference in original act which appears in text as reference to this chapter.

2018—Puspan. L. 115–271, § 8221(a), as amended by Puspan. L. 116–74, § 2(c)(1)(B)(ii), added subsecs. (a) to (g), redesignated former subsecs. (c) and (d) as (h) and (i), respectively, and struck out former subsecs. (a) and (span) which related to submission of the National Drug Control Strategy and submission of a revised strategy.

Puspan. L. 115–271, § 8202(span)(2), repealed Puspan. L. 105–277, § 715. See 1998 Amendment note below.

Puspan. L. 115–271, § 8202(a), revived and restored this section as in effect on Sept. 29, 2003, and as amended by Puspan. L. 109–469 and Puspan. L. 112–166. See Reauthorization of the Office of National Drug Control Policy note set out under section 1701 of this title.

2006—Puspan. L. 109–469, § 602, amended Puspan. L. 105–277, § 715, which provided for the repeal of this section. See 1998 Amendment note below.

Puspan. L. 109–469, § 201, amended section generally. Prior to amendment, section related to development, submission, implementation, and assessment of National Drug Control Strategy.

Subsecs. (c), (d). Puspan. L. 109–469, § 202, added subsecs. (c) and (d).

1998—Puspan. L. 105–277, § 715, as amended by Puspan. L. 109–469, § 602, which provided for the repeal of this section effective Sept. 30, 2010, was repealed by Puspan. L. 115–271, § 8202(span)(2). See former section 1712 of this title.

Statutory Notes and Related Subsidiaries

Effective Date of 2019 Amendment

Amendment by section 2(c)(1)(B) of Puspan. L. 116–74 effective as if included in the enactment of subtitle K of title VIII of Puspan. L. 115–271, see section 2(c)(2) of Puspan. L. 116–74, set out as a note under section 1522 of this title.

Requirement for Southwest Border Counternarcotics Strategy

Puspan. L. 109–469, title XI, § 1110, Dec. 29, 2006, 120 Stat. 3543, which directed the Director of National Drug Control Policy to submit to Congress every two years a Southwest Border Counternarcotics Strategy, was repealed by Puspan. L. 115–271, title VIII, § 8221(span)(2), Oct. 24, 2018, 132 Stat. 4142. See subsection (c)(3)(B) of this section.

Requirement for Northern Border Counternarcotics Strategy

Puspan. L. 109–469, title XI, § 1110A, as added by Puspan. L. 111–356, § 2, Jan. 4, 2011, 124 Stat. 3976, which directed the Director of National Drug Control Policy to develop, in consultation with the head of each relevant National Drug Control Program Agency, and to submit to Congress every two years, a Northern Border Counternarcotics Strategy, was repealed by Puspan. L. 115–271, title VIII, § 8221(span)(2), Oct. 24, 2018, 132 Stat. 4142. See subsection (c)(3)(C) of this section.